Longitudinal Changes in Relative Market Share Proportions of Biologic, and Targeted Synthetic, Disease-Modifying Anti-Rheumatic Drugs (DMARDs) for Treatment of Rheumatoid Arthritis: Results from the Ontario Best Practices Research Initiative (OBRI) Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Hepworth, Elliot
  • Movahedi, Mohammad
  • Rampakakis, Emmanouil
  • Mirza, Reza
  • Lau, Arthur
  • Cesta, Angela
  • Pope, Janet
  • Sampalis, John
  • Bombardier, Claire

publication date

  • July 1, 2019